Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)(TERMINATED)

NCT00423150 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

86

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Neoplasm
Head and Neck Neoplasm
Carcinoma, Non-Small-Cell Lung
Esophageal Neoplasm

Interventions

DRUG: Temozolomide

Sponsor

Merck Sharp & Dohme LLC